GGrantIndex
← Search

Shared Resource Management

$1,210,757P30FY2024CANIH

University Of Wisconsin-Madison, Madison WI

Investigators

Linked publications, trials & patents

Paper 39638850Paper 39604703Paper 39580301Paper 39530524Paper 39527745Paper 39516197Paper 39484544Paper 39481346Paper 39474803Paper 39462136Paper 39452931Paper 39444276Paper 39443360Paper 39432401Paper 39414902Paper 39408582Paper 39407431Paper 39402986Paper 39399121Paper 39386576Paper 39386545Paper 39379374Paper 39374311Paper 39364328Paper 39358429Paper 39345631Paper 39335130Paper 39312186Trial NCT06608511Trial NCT06557733Trial NCT05985681Trial NCT05521698Trial NCT05107219Trial NCT03725761Trial NCT03722030Trial NCT03703492Trial NCT03656276Trial NCT03393741Trial NCT03387514Trial NCT03358563Trial NCT03356470Trial NCT03342378Trial NCT03304002Trial NCT03300557Trial NCT03209869Trial NCT03185871Trial NCT03028584Trial NCT03023202Trial NCT02955043Trial NCT02917629Trial NCT02876640Trial NCT02780401Trial NCT02719821Trial NCT02169284Trial NCT02096783Trial NCT02095145Trial NCT01999881Trial NCT01935960Trial NCT01901835Trial NCT01707004Trial NCT01625156Trial NCT01325311Trial NCT01263613Trial NCT01245205Trial NCT01243359Trial NCT01233505Trial NCT01218620Trial NCT01217450Trial NCT01158274Trial NCT01083641Trial NCT01004796Trial NCT00896974Trial NCT00666562Trial NCT00544596Trial NCT00499135Trial NCT00462969Trial NCT00415025Trial NCT00410605Trial NCT00227513Trial NCT00138203Trial NCT00109863Trial NCT00079014Trial NCT00052832Trial NCT00049712Trial NCT00036790Trial NCT00028652Trial NCT00023855Trial NCT00022412Trial NCT00005794Trial NCT00004872Patent 9867974Patent 9763597Patent 9603567Patent 9470697Patent 9161720Patent 8871458Patent 6974254Patent 6438202Patent 6114119Patent 6020178

Abstract

PROJECT SUMMARY – SHARED RESOURCE MANAGEMENT (SRM) The University of Wisconsin Carbone Cancer Center (UWCCC) provides scientific and administrative oversight and allocates funds from the Cancer Center Support Grant (CCSG) and other sources to support 12 Shared Resources (SRs). These SRs serve the vast majority of UWCCC members and advance the Center’s strategic research initiatives. Each SR is led by an expert faculty leader, who is a UWCCC member, and a highly experienced facility manager. Dr. Jim Shull (Cancer Genetic and Epigenetic Mechanisms (GEM)) has served as Associate Director for Shared Resources (ADSR) since 2009, and Ms. Dawn Church has served as Assistant Director for Shared Resources (AsstDSR) since 2015. The mission of our Shared Resources Management (SRM) team is to provide UWCCC members with access to cost effective, state-of-the-art research infrastructure and world class expertise that enable cancer-focused research along the entire basic to community/population research continuum. Aim 1 is to establish, manage, and support SRs that advance the research of the UWCCC membership. SRM engages UWCCC leadership to match the services provided by our SRs to the defined needs of our members; to maximize cost effectiveness; and to ensure that our SRs evolve in a manner that aligns with UWCCC’s strategic priorities. SRM strives to attain management and operations consistencies across all SRs. Aim 2 is to engage UW leaders to secure institutional support for the UWCCC SRs. SRM works closely with leaders within the School of Medicine and Public Health (SMPH) and other UW leaders to secure/sustain institutional support, minimize redundancies in services existing across the UW campus, and leverage the immense scale of the UW research enterprise when negotiating with equipment, supply, and service vendors. Aim 3 is to develop and implement effective marketing and evaluation tools and strategies. These tools and strategies educate our membership and the entire UW research community of our SRs’ services, technical capabilities, and expertise, and inform our SR faculty leaders and managers and UWCCC leadership of the value of the services provided by our SRs and the changing needs of our member users. Approximately 90% of all UWCCC program members utilized one or more of our SRs during the 2017-2021 CCSG cycle. Member SR users collectively held 735 cancer-relevant research grants totaling $75.7 million on December 31, 2021, including 130 awards from the National Cancer Institute (NCI) totaling $26 million in annual direct costs. Survey data indicate our SRs are highly valued by the UWCCC and broader UW research communities and virtually all our members indicate their research programs would be severely compromised if our SRs did not exist. Our SRs received the aggregate merit rating of outstanding at the 2017 review of the CCSG. Since that review, the UWCCC and our UW partners have established 3 new SRs, reorganized/expanded/enhanced all remaining SRs, and invested more than $32 million to support SR operations, enhance SR infrastructure, and optimally align SR capabilities to the needs of our members.

View original record on NIH RePORTER →